These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20342854)

  • 61. A case of angiographically verified non-occlusive mesentery ischemia induced by digitalis.
    Kayahan H; Topalak O; Göktay Y; Soytürk M; Meral M; Başaran K; Dağlar O
    Turk J Gastroenterol; 2008 Jun; 19(2):125-8. PubMed ID: 19110670
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Influence of vasoexcitor-pressor drugs on microvascular injury in shock.
    Hershey SG; Altura BM
    Bibl Anat; 1967; 9():33-7. PubMed ID: 4291515
    [No Abstract]   [Full Text] [Related]  

  • 63. Effect of dibenamine on renal blood flow in hemorrhagic shock.
    BRANDFONBRENER M; GELLER HM
    Am J Physiol; 1952 Nov; 171(2):482-6. PubMed ID: 13007820
    [No Abstract]   [Full Text] [Related]  

  • 64. Splenectomy Versus Sham Splenectomy in a Swine Model of Controlled Hemorrhagic Shock.
    Boysen SR; Caulkett NA; Brookfield CE; Warren A; Pang JM
    Shock; 2016 Oct; 46(4):439-46. PubMed ID: 26974424
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bacterial factor in experimental hemorrhagic shock; evidence for development of a bacterial factor which accounts for irreversibility to transfusion and for the loss of the normal capacity to destroy bacteria.
    SCHWEINBURG FB; FRANK HA; FINE J
    Am J Physiol; 1954 Dec; 179(3):532-40. PubMed ID: 13228624
    [No Abstract]   [Full Text] [Related]  

  • 66. [Splanchnic circulation in the course of hemorrhage].
    LACROIX E
    J Physiol (Paris); 1963; 55():276-7. PubMed ID: 13927971
    [No Abstract]   [Full Text] [Related]  

  • 67. [The treatment of irreversible shock with "pharmacological" doses of corticosteroids: effects on mesenteric hemodynamics and possible mechanism of action].
    Novelli GP; Zampolini M; Pallini C; Celiberti A; Cortesini C
    Minerva Anestesiol; 1967 Apr; 33(4):310-7. PubMed ID: 5613775
    [No Abstract]   [Full Text] [Related]  

  • 68. Use of octreotide in the treatment of mesenteric angina.
    Anderson SH; Dalton HR
    Am J Gastroenterol; 1997 Jul; 92(7):1222-3. PubMed ID: 9219806
    [TBL] [Abstract][Full Text] [Related]  

  • 69. C1-esterase-inhibitor treatment at early reperfusion of hemorrhagic shock reduces mesentry leukocyte adhesion and rolling.
    Horstick G; Kempf T; Lauterbach M; Bhakdi S; Kopacz L; Heimann A; Malzahn M; Horstick M; Meyer J; Kempski O
    Microcirculation; 2001 Dec; 8(6):427-33. PubMed ID: 11781815
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Changes in the splanchnic circulation after haemorrhage.
    REYNELL PC
    Gastroenterologia; 1954 Feb; 81(2):72-3. PubMed ID: 13151354
    [No Abstract]   [Full Text] [Related]  

  • 71. The clinics of disturbances of the blood circulation in the vessels of the mesentery in relation to thrombosis and emboli.
    ZEMETZ AA
    Klin Med (Mosk); 1945; 23(6):50-6. PubMed ID: 21013687
    [No Abstract]   [Full Text] [Related]  

  • 72. Pulmonary and peripheral circulation times in haemorrhagic shock.
    MUKHERJEE SR; ROWLANDS S
    Lancet; 1951 May; 1(6663):1041-3. PubMed ID: 14825897
    [No Abstract]   [Full Text] [Related]  

  • 73. Predisposing action of anesthetic agents on the vascular responses in hemorrhagic shock.
    ZWEIFACH BW; HERSHEY SG
    Surg Gynecol Obstet; 1949 Oct; 89(4):469-77. PubMed ID: 18137102
    [No Abstract]   [Full Text] [Related]  

  • 74. [Peripheral circulatory insufficiency; shock].
    NOGUEIRA JUNIOR A
    Med Cir Farm; 1946; (121):242-76. PubMed ID: 20990068
    [No Abstract]   [Full Text] [Related]  

  • 75. Medical shock: abnormal biochemical changes in patients with severe, acute medical illnesses, with and without peripheral vascular failure.
    Davidson CS; Lewis JH
    N Engl J Med; 1946 Feb; 234():279-88. PubMed ID: 21016457
    [No Abstract]   [Full Text] [Related]  

  • 76. Host resistance to hemorrhagic shock. XI. Role of deficient flow through intestine in development of irreversibility.
    SHAPIRO PB; BRONSTHER B; FRANK ED; FINE J
    Proc Soc Exp Biol Med; 1958 Feb; 97(2):372-6. PubMed ID: 13518279
    [No Abstract]   [Full Text] [Related]  

  • 77. Portal circulation in experimental hemorrhagic shock; in vivo roentgen ray studies.
    FRIEDMAN EW; FRANK HA; FINE J
    Ann Surg; 1951 Jul; 134(1):70-9. PubMed ID: 14838541
    [No Abstract]   [Full Text] [Related]  

  • 78. Prognostic signs in experimental hemorrhagic shock.
    GLASSER O; PAGE IH
    Cleve Clin Q; 1946 Jul; 13():125-7. PubMed ID: 20987355
    [No Abstract]   [Full Text] [Related]  

  • 79. Hemorrhagic shock.
    SWINDLER CM
    Am J Surg; 1948 Aug; 76(2):182-7. PubMed ID: 18876744
    [No Abstract]   [Full Text] [Related]  

  • 80. On the Specific Role of the Liver in Hemorrhagic Shock: Report of Progress to Date.
    Fine J; Seligman AM; Frank HA
    Ann Surg; 1947 Dec; 126(6):1002-9. PubMed ID: 17859038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.